You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glaucoma-related Adverse Events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lens Implantation, Intraocular Trial in Guangzhou (Secondary in-the-bag IOL fixation, Secondary ciliary sulcus IOL fixation)

Recruiting
  • Lens Implantation, Intraocular
  • Secondary in-the-bag IOL fixation
  • Secondary ciliary sulcus IOL fixation
  • Guangzhou, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, C
Jan 6, 2022

Cancer, Immune-related Adverse Event Trial in Durham (Medical chart review)

Enrolling by invitation
  • Cancer
  • Immune-related Adverse Event
  • Medical chart review
  • Durham, North Carolina
    Duke University Medical Center
Oct 20, 2023

EXploring Immune-related Adverse Events of Immune checkpoinT

Active, not recruiting
  • Cancer
  • +2 more
  • Immune checkpoint inhibitor
  • Paris, France
  • +1 more
Jul 5, 2023

Adverse Events Related to Low Dose Atropine

Active, not recruiting
  • Myopia, Progressive
  • Atropine Sulfate
  • San Diego, California
    Laura Kirkeby
Jan 4, 2023

Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

Recruiting
  • Immunotherapy
  • +5 more
  • blood retriewal
  • Amiens, Picardie, France
    CHU Amiens Picardie
Apr 3, 2023

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

Completed
  • Immune Checkpoint Inhibitor
  • Endocrine Toxicity
    • Nanjing, Jiangsu, China
      First Affiliated Hospital, Nanjing Medical University
    Jan 6, 2023

    Immune-related Adverse Events Refractory to Standard Therapy and

    Recruiting
    • Immune-related Adverse Event
    • Extracorporeal photopheresis
    • Other immunosuppressive or immunomodulatory drugs
    • Munich, Germany
      LMU Klinikum Hauttumorzentrum
    Jan 17, 2023

    Open-angle Glaucoma, OAG Trial in China (XEN45 Glaucoma Treatment System, Trabeculectomy)

    Not yet recruiting
    • Open-angle Glaucoma
    • OAG
    • XEN45 Glaucoma Treatment System
    • Trabeculectomy
    • Beijing, Beijing, China
    • +11 more
    Apr 18, 2023

    Neurological Immune-related Adverse Events

    Recruiting
    • Neurological Disease
    • Analysis of biomarkers and their correlation with clinical characteristics and outcome
    • Bron, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 28, 2023

    Tonsillectomy, Adenoidectomy, Drug-Related Side Effects and Adverse Reaction Trial in Cairo (The midazolam group, The midazolam

    Recruiting
    • Tonsillectomy
    • +2 more
    • The midazolam group
    • The midazolam ketamine group
    • Cairo, Egypt
      Cairo university hospitals, kasralainy
    Nov 7, 2023

    Sleep Disordered Breathing, Endothelial Function, and Adverse

    Recruiting
    • Pregnancy Related
    • Sleep-Disordered Breathing
      • Edmonton, Alberta, Canada
        Program for Pregnancy and Postpartum Health, University of Alber
      Jun 9, 2023

      6 Provinces in Central China

      Recruiting
      • Anesthesia-related Quality Control Indicators
      • Anesthesia-related Adverse Events
        • Wuhan, Hubei, China
          Union Hospital, Tongji Medical College, Huazhong University of S
        Jun 28, 2023

        Loiasis Trial in Yaoundé (Ivermectin)

        Completed
        Has Results
        • Loiasis
        • Yaoundé, Cameroon
          Centre de Recherche sur les Filarioses et autres Maladies Tropic
        Aug 30, 2022

        Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

        Not yet recruiting
        • Hematopoietic and Lymphoid Cell Neoplasm
        • Malignant Solid Neoplasm
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Dec 20, 2022

        Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)

        Recruiting
        • Immune Related Adverse Events
        • +3 more
        • Freiburg, Baden-Württemberg, Germany
          Medical Center - University of Freiburg Albert-Ludwigs-Universit
        Jun 9, 2022

        Adverse Events-related Healthcare Resource Utilization and Costs

        Completed
        • Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Jan 27, 2023

        Patient Acceptance of Health Care, Acute Renal Failure Trial (Clinical decision support, Will not receive Clinical Decision

        Not yet recruiting
        • Patient Acceptance of Health Care
        • Acute Renal Failure
        • Clinical decision support
        • Will not receive Clinical Decision Support
        • (no location specified)
        Jun 26, 2023

        Adverse Events in Patients Treated With Immune Check Point

        Recruiting
        • Immune-related Adverse Event
        • Antiinflammatory/DMARDs
        • Kristiansand, Norway
        • +4 more
        Sep 15, 2022

        Adverse Drug Events Associated With Initiation of Drugs

        Completed
        • COVID
        • +3 more
        • Simulation of Repurposed Drugs for COVID-19
        • Orlando, Florida
          Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
        Jan 30, 2023

        Suspicion of Cardiovascular Events on Immunecheckpoint

        Recruiting
        • Cancer
        • +3 more
        • No intervention for research purposes only
        • Paris, France
          Intitut Mutualiste Montsouris
        Mar 23, 2023

        Open-Angle Glaucoma Trial in United States (XEN45 (Glaucoma Gel Stent))

        Recruiting
        • Open-Angle Glaucoma
        • XEN45 (Glaucoma Gel Stent)
        • Fayetteville, Arkansas
        • +20 more
        Dec 22, 2022

        Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

        Recruiting
        • Chronic Myeloid Leukemia in Chronic Phase
        • Shenzhen, Guangdong, China
          Shenzhen Second People's Hospital
        Jul 26, 2022

        Cancer, Immune System Disorder, Inflammatory Reaction Trial in Montreal

        Recruiting
        • Cancer
        • +3 more
          • Montreal, Quebec, Canada
            Jewish General Hospital
          Nov 30, 2021

          Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,

          Terminated
          Has Results
          • Advanced Malignant Solid Neoplasm
          • CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
          • Placebo Administration
          • Sacramento, California
            University of California Davis Comprehensive Cancer Center
          Mar 8, 2022

          Healthcare Resource Utilization and Costs of Immune Checkpoint

          Completed
          • Melanoma
            • East Hanover, New Jersey
              Novartis
            May 12, 2023